Mar 29 - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

Mar 29

Description:

depressed mood or loss of interest for at least 2 weeks. slowing down of ... gut, MAOs, especially MAO B break down several food stuffs; importantly tyramine ... – PowerPoint PPT presentation

Number of Views:66
Avg rating:3.0/5.0
Slides: 31
Provided by: janea2
Category:

less

Transcript and Presenter's Notes

Title: Mar 29


1
Mar 29 Depression and the Older Antidepressants
2
  • Major Depressive Disorder
  • Symptoms
  • depressed mood or loss of interest for at least 2
    weeks
  • slowing down of behavior - slowed speech
  • feelings of worthlessness or extreme guilt
  • difficulty concentrating
  • sleep disturbances
  • recurrent thoughts of death or suicide

3
  • Major Depressive Disorder
  • difficulty concentrating
  • sleep disturbances
  • recurrent thoughts of death or suicide not due to
    illness or acute grief
  • must be of degree to interfere with social,
    occupational, and other important functioning

4
  • Major Depressive Disorder
  • Facts
  • at some point in life, depression effects 5-12
    of males and 10-25 of females
  • (twice as common in women)
  • prevalence is not related to educational level,
    income level, ethnicity
  • among people who experience depression at some
    point in life, 50 have more than one episode

5
  • Biological Causes
  • 1. Genetic influences
  • Monozygotic twins - 40-65 concordance (chance
    that if one twin has it, the other does too)
  • Dizygotic twins - 10-20 concordance
  • 2. Neurochemical characteristics
  • a. reduced levels of metabolites of
    norepinephrine in cerebrospinal fluid and urine

6
  • Biological Causes
  • 2. Neurochemical characteristics
  • b. abnormal endocrine functions controlled by
    norepinephrine
  • High cortisol levels due to dysfunction in
    hypothalamic-pituitary-adrenal axis control
    system
  • Neurons in hypothalamus use norepinephrine
    as the neurotransmitter that tells other
    hypothalamic neurons to stop releasing
    Corticotropin Releasing Factor (CRF).

7
The hypothalamic-pituitary-adrenal axis Stress
stimulates neurons in the hypothalamus to release
corticotropin-releasing factor (CRF) CRF
stimulates limbic system- emotional response
(how?) CRF stimulates anterior pituitary to
release adrenocorticotrophic hormone (ACTH).
(How?) ACTH stimulates release of
glucocorticoids from the adrenal cortex.
8
(No Transcript)
9
  • 2. Neurochemical characteristics
  • b. abnormal endocrine functions controlled by
    norepinephrine - high cortisol levels
  • c. abnormal response on dexamethasone suppression
    test
  • Dexamethasone - synthetic cortisol.
  • Measure cortisol levels at 1100 PM
  • Then give dexamethasone.
  • In AM, should have lower cortisol.
  • Not so in many depressed people.
  • Improved by antidepressant meds

10
CRH receptor antagonists under development
for use as antidepressants
11
  • 2. Neurochemical characteristics
  • d. reduced levels of metabolites of serotonin
    (respond to drugs that increase serotonin)
  • e. Increased density of NE and 5HT2 receptors
    (suggest adaptation to reduced levels of
    neurotransmitters)
  • f. Serotonin plays an important role in blood
    platelets which helps protect them from excess
    clumping. Among depressed, more platelet
    aggregation is seen, along with increased risk
    for heart attack and stroke.
  • g. drugs that block or deplete NE or SE can cause
    depression (Reserpine and certain drugs used to
    treat high blood pressure)

12
  • 2. Neurochemical characteristics
  • g. drugs that block or deplete NE or SE can cause
    depression
  • h. animals showing learned helplessness have
    reduced levels of NE and SE (and elevated
    cortisol)

13
  • 3. Illnesses that may produce depression
  • Cushings Syndrome (85)
  • Pituitary tumors produce too much ACTH --gt then
    adrenals release too much cortisol
  • or
  • Adrenal tumors may produce too much cortisol.
  • Excessive treatment with corticosteroids may
    mimic syndrome.
  • All causes lead to obesity and unusual body hair
    growth

14
  • 3. Illnesses that may produce depression
  • Cushings Syndrome (85)
  • Thyroid disorders (underactive - depression
    overactive - excessive energy reduced sleep
    needs possible mania)
  • Parkinsons Disease (50)
  • Substance abuse disorders
  • Long term use of certain drugs at high levels
    alters relevant neurochemical systems (NE, DA,
    SE) - Cocaine, Methamphetamine Ecstasy.

15
  • Suicide
  • 80 of those who commit suicide suffer from
    depression or bipolar disorder
  • among the depressed, 15 commit suicide each year
  • suicide victims have lower concentrations of
    serotonin in their brain
  • suicide victims show high levels of cortisol

16
  • General Health
  • Depression increases the risk of dying after
    heart attack or stroke (mood? blood?)
  • Chronic overactivation of the stress circuit
    increases risk for heart disease and stroke

17
  • Drugs Used to Treat Depressive Disorders
  • MAO inhibitors
  • 2. Tricyclic antidepressants
  • 3. Selective Serotonin Reuptake Inhibitors

18
  • II. Antidepressants
  • A. Monoamine Oxidase Inhibitors
  • in early 1950s, iproniazid, used to treat
    tuberculosis, was noted to elevate mood
  • use as antidepressant began in late 1950s, but
    caused liver toxicity
  • other drugs then developed, but use has always
    been limited by severe side effects
  • used for those who do not respond to tricyclic
    antidepressants or SSRIs
  • Phenylzine (Nardil)
  • Isocarboxazid (Marplan)
  • Tranylcypromine (Parnate)
  • Selegiline (Eldepryl)
  • Moclobemide (Manorix Aurorix)
  • Brofaromine (Consonar)

19
  • Pharmacodynamics
  • inhibition of monoamine oxidase(s) the enzyme
    family that breaks down monoamine transmitters,
    NE, E, DA, SE following reuptake
  • there are 2 MAO types A and B
  • MAO A breaks down E, NE, DA, and SE within
    neurons and some glial cells
  • MAO B breaks down DA in nigrostriatal regions
    also breaks down tyramine and other substances in
    neurons and some glial cells (protects the
    neuron)
  • does not break down the neurotransmitters inside
    vesicles only the ones found or reuptaken into
    cytoplasm
  • in gut, MAOs, especially MAO B break down
    several food stuffs importantly tyramine

20
  • Unpleasant, possibly Life-Threatening Drug-Food
    Interaction
  • in gut, MAOs, especially MAO B break down
    several food stuffs importantly tyramine
  • inhibition of breakdown by MAO due to these
    drugs leads to buildup of tyramine which causes
    toxic sympathomimetic effects
  • these coupled with elevated actions of NE lead
    to dangerous hypertensive crisis elevated blood
    pressure heart rate increase, severe occipital
    headache motor agitation, sweating -gt if
    untreated, stroke, loss of consciousness, death
  • effects occur in 20 min- 1 hour after ingestion
    of the food containing tyramine
  • must avoid aged foods cheese, sausages,
    alcohols, sauerkraut, pickled or fermented foods,
    and others

21
Foods to Avoid on MAOI Diet aged cheese aged
or cured meats (e.g., air-dried sausage) any
potentially spoiled meat, poultry, or fish broad
(fava) bean pods Marmite concentrated yeast
extract sauerkraut soy sauce and soy bean
condiments tap beer Wine domestic
bottled/canned beer in moderation
22
Other Side Effects Dizziness Fatigue Headache
Jaundice Dry mouth Anorgasmia Insomnia
Erectile dysfunction Postural hypotension
Blurred vision Urinary retention/hesitancy
Nausea Peripheral edema Constipation Muscle
weakness/jerking Multiple reasons beyond just
brain-based actions.
23
A. Monoamine Oxidase Inhibitors Phenylzine
(Nardil) - non-selective and irreversible Isocarbo
xazid (Marplan) - non-selective and
irreversible Tranylcypromine (Parnate) -
non-selective and irreversible Selegiline
(Eldepryl) selective B, irreversible Moclobemide
(Manorix Aurorix)- selective A and reversible
Brofaromine (Consonar) - selective A and
reversible Taken orally Delayed action Efficacy
of 70-80 for reduction of depressive symptoms.
24
  • B. Tricyclic Antidepressants (and tetracyclic)
  • main treatment for depression from 1960-1980
  • still among best treatments for the moderately
    to severely depressed (non-delusional) person
    80 response
  • many side effects and poor safety margin
  • oldest is Imipramine (Tofranil)
  • 10 are on US market

25
B. Tricyclic Antidepressants (and
tetracyclic) Imipramine (Tofranil) Desipramine
(Norpramin) Amitriptyline (Elavil) Nortriptyline
(Aventyl Pamelor) Clomipramine
(Anafranil) Trimipramine (Surmontil) Doxepin
(Sinequan Adapin) Protriptyline
(Vivactil) Amoxapine (Asendin) Maprotiline
(Ludiomil)
26
  • Pharmacokinetics
  • Well absorbed orally
  • Peak in 2-6 hours
  • Individual differences in metabolism slow
    metabolizers and fast metabolizers
  • Liver metabolism by CYP2D6
  • Renal clearance
  • Most TCAs have half-life around 24 hours
  • Allows once/day dosing for all
  • Elderly may need lower doses
  • Very narrow therapeutic index 6-10 with fatal
    cardiac arrhythmias as cause of death (can
    overdose on a 1 week supply)
  • Plasma concentrations are monitored

27
  • Pharmacodynamics
  • vary in ratio of blocking NE and SE reuptake
    all block NE
  • also block muscarinic cholinergic receptors,
    alpha receptors for NE in PNS, and histamine
    receptors
  • Actions on NE (and SE) occur within hours, but
    depression reduction takes 1-2 weeks Why?
  • 1. Receptor Sensitivity Hypothesis correlates
    of depressive symptom reduction
  • With repeated increase in the NE supply due to
    tricyclic action, beta adrenergic receptors for
    NE in brain down regulate by reducing in number
  • Also enhanced serotonergic transmission at 5HT1A
    receptors alongside down regulation of 5HT2
    receptors

28
1. Receptor Sensitivity Hypothesis correlates
of depressive symptom reduction With repeated
increase in the NE supply due to tricyclic
action, beta adrenergic receptors for NE in brain
down regulate by reducing in number Also enhanced
serotonergic transmission at 5HT1A receptors 2.
May stimulate neuronal proliferation and increase
number of neurons in limbic areas (fits with idea
that stress ultimately destroys hippocampal
neurons as part of how chronic stress may cause
depression)
29
Tricyclic Action Side effects
  • Reuptake blockade of NE heart arrhythmias
  • Blockade of Muscarinic Receptors Dry mouth and
    eyes
  • (anticholinergic effects) Urinary retention
  • Constipation
  • Blurred vision
  • Confusion-gt Delirium
  • Blockade of alpha-NE Postural hypotension
  • receptors in the PNS Dizziness
  • (anti-adrenergic effects) Drowsiness
  • Blockade of histamine receptors Sedation
  • Weight gain
  • (15 lbs in 6mo)

30
  • Tricyclic Antidepressants Drug Interactions
  • based on liver enzyme competition or induction
  • Prozac and TCAs TCA levels build up to
    dangerous level
  • MAOIs also dangerous stroke seizures
  • Haloperidol and Phenothiazines (antipsychotics)
    can block metabolism of TCAs they build up
  • Barbiturates induce metabolism - need higher
    dose of TCAs
  • Phenytoin (Dilantin) Phenytoin may be elevated
    into toxic range
Write a Comment
User Comments (0)
About PowerShow.com